×
Close
註冊
登入
主页
医学图书S馆
医学图书D馆
活动
Upcoming Events
Past Events
用户工具
用户指南
语言
English
中文/ Chinese
French
Português
Español
Arabic
Russian
×
Close
mdla_1
mdla_2
mdla_3
mdla_4
mdla_5
mdla_6
分类
Hematology
5456
Global Medical University
5020
Allergy
1783
Anatomy & Morphology
1527
Andrology
414
Anesthesia & Intensive Care
1214
Anesthesiology
5442
Audiology & Speech-Language Pathology
332
Behavioral Sciences
100
Biochemical Research Methods
6818
Biochemistry & Molecular Biology
29335
Biodiversity Conservation
288
Biology
8218
Biophysics
8099
Biotechnology & Applied Microbiology
8197
Cardiac & Cardiovascular Systems
30752
Cardiovascular & Respiratory Systems
1391
Cell & Tissue Engineering
654
Cell Biology
10825
Chemistry, Analytical
4216
Chemistry, Applied
11003
Chemistry, Medicinal
8487
Chemistry, Multidisciplinary
18503
Clinical Immunology & Infectious Disease
442
Clinical Medicine
8751
Clinical Neurology
16238
Clinical Psychology & Psychiatry
1298
Critical Care Medicine
3153
Dentistry, Oral Surgery & Medicine
12959
Dermatology
7601
Developmental Biology
6915
Ecology
645
Education, Scientific Disciplines
1886
Emergency Medicine
3981
Endocrinology, Metabolism & Nutrition
23582
Engineering, Biomedical
3586
Entomology
425
Environmental Medicine & Public Health
4623
Evolutionary Biology
254
Gastroenterology & Hepatology
11883
General & Internal Medicine
6948
Genetics & Heredity
14711
Geriatrics & Gerontology
5022
Gerontology
338
Health Care Sciences & Services
15636
Health Policy & Services
594
Immunology
24666
Infectious Diseases
13671
Integrative & Complementary Medicine
2758
Medical Ethics
1146
Medical Informatics
2117
Medical Laboratory Technology
433
Medicine, General & Internal
44233
Medicine, Legal
493
Medicine, Research & Experimental
17436
Microbiology
22758
Mycology
0
Nanoscience & Nanotechnology
5039
Neuroimaging
1293
Neurology
4396
Neurosciences
38942
Nursing
9355
Nutrition & Dietetics
7802
Obstetrics & Gynecology
8102
Oncology
51594
Ophthalmology
9493
Optics
4025
Orthopedics
11367
Orthopedics, Rehabilitation & Sports Medicine
1729
Otolaryngology
1505
Otorhinolaryngology
4791
Parasitology
1040
Pathology
4888
Pediatrics
21065
Peripheral Vascular Disease
4693
Pharmacology & Pharmacy
33972
Pharmacology/Toxicology
12027
Physiology
8875
Polymer Science
539
Primary Health Care
795
Psychiatry
18891
Psychology
5053
Psychology, Applied
92
Psychology, Biological
335
Psychology, Clinical
785
Psychology, Developmental
222
Psychology, Educational
149
Psychology, Experimental
122
Psychology, Mathematical
0
Psychology, Multidisciplinary
1590
Psychology, Psychoanalysis
41
Psychology, Social
114
Public Health & Health Care Science
2227
Public, Environmental & Occupational Health
26926
Quantum Science & Technology
0
Radiology, Nuclear Medicine & Imaging
12032
Radiology, Nuclear Medicine & Medical Imaging
7772
Rehabilitation
2967
Remote Sensing
0
Reproductive Biology
2745
Reproductive Medicine
1131
Research/Laboratory Medicine & Medical Technology
3872
Respiratory System
7101
Rheumatology
5751
Social Sciences, Biomedical
1176
Substance Abuse
2676
Surgery
33275
Toxicology
4241
Transplantation
927
Tropical Medicine
314
Urology & Nephrology
12745
Veterinary Sciences
35
Virology
2383
Zoology
0
渠道
EXPERIMENTAL HEMATOLOGY & ONCOLOGY
224
Hematology\Oncology
3
Medrxiv - Hematology
184
AMERICAN JOURNAL OF HEMATOLOGY
248
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
20
BLOOD CANCER JOURNAL
448
BRITISH JOURNAL OF HAEMATOLOGY
460
CIRCULATION RESEARCH
383
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
532
HAEMOPHILIA
143
JOURNAL OF CLINICAL APHERESIS
57
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
258
LANCET HAEMATOLOGY
29
THERAPEUTIC ADVANCES IN HEMATOLOGY
35
ACTA HAEMATOLOGICA
159
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
141
BLOOD COAGULATION & FIBRINOLYSIS
66
BLOOD PURIFICATION
188
CURRENT OPINION IN HEMATOLOGY
41
EUROPEAN JOURNAL OF HAEMATOLOGY
95
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY
231
HAMOSTASEOLOGIE
176
ASIAN JOURNAL OF TRANSFUSION SCIENCE
20
EGYPTIAN JOURNAL OF HAEMATOLOGY
35
HEMASPHERE
404
HEMATOLOGY REPORTS
17
IRAQI JOURNAL OF HEMATOLOGY
88
CURRENT HEMATOLOGIC MALIGNANCY REPORTS
107
INTERNATIONAL JOURNAL OF HEMATOLOGY
543
JOURNAL OF HEMATOPATHOLOGY
121
SCI时时刷
search
全部
推荐
+
Cytokine-based models for efficient differentiation between infection and cytokine release syndrome in patients with hematological malignancies
Although the efficacy of chimeric antigen receptor (CAR)-T cell therapy has been widely demonstrated, its clinical applica...
Experimental Hematology & Oncology
comment
0
thumb_up
0
MSCsDB: a database of single-cell transcriptomic profiles and in-depth comprehensive analyses of human mesenchymal stem cells
Mesenchymal stem cells (MSCs) possess multipotent properties that make them promising candidates for immunomodulation and ...
Experimental Hematology & Oncology
comment
0
thumb_up
0
Suppression of A-to-I RNA-editing enzyme ADAR1 sensitizes hepatocellular carcinoma cells to oxidative stress through regulating Keap1/Nrf2 pathway
A-to-I RNA editing is an abundant post-transcriptional modification event in hepatocellular carcinoma (HCC). Evidence sugg...
Experimental Hematology & Oncology
comment
0
thumb_up
0
Harnessing ferroptosis for enhanced sarcoma treatment: mechanisms, progress and prospects
Sarcoma is a malignant tumor that originates from mesenchymal tissue. The common treatment for sarcoma is surgery suppleme...
Experimental Hematology & Oncology
comment
0
thumb_up
0
Ubiquitin ligase subunit FBXO9 inhibits V-ATPase assembly and impedes lung cancer metastasis
The evolutionarily conserved protein FBXO9 acts as a substrate receptor for the SKP1-cullin-1-RBX1 ubiquitin ligase and is...
Experimental Hematology & Oncology
comment
0
thumb_up
0
The role of pyroptosis and gasdermin family in tumor progression and immune microenvironment
Pyroptosis, an inflammatory programmed cell death, distinguishes itself from apoptosis and necroptosis and has drawn incre...
Experimental Hematology & Oncology
comment
0
thumb_up
0
Antitumor effect of a small-molecule inhibitor of KRASG12D in xenograft models of mucinous appendicular neoplasms
Pseudomyxoma peritonei (PMP) is a rare disease characterized by a massive accumulation of mucus in the peritoneal...
Experimental Hematology & Oncology
comment
0
thumb_up
0
A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary disease
Differentiating between pancreatic ductal adenocarcinoma (PDAC) and cholangiocarcinoma (CCA) is crucial for the appropriat...
Experimental Hematology & Oncology
comment
0
thumb_up
0
Upregulated PARP1 confers breast cancer resistance to CDK4/6 inhibitors via YB-1 phosphorylation
Cyclic-dependent kinase (CDK) 4/6 kinases, as the critical drivers of the cell cycle, are involved in the tumor progressio...
Experimental Hematology & Oncology
comment
0
thumb_up
0
Immune checkpoint inhibitors for multiple myeloma immunotherapy
Multiple myeloma (MM) is related to immune disorders, recent studys have revealed that immunotherapy can greatly benefit M...
Experimental Hematology & Oncology
comment
0
thumb_up
0
Molecular characterization of the CXCR4 / CXCR7 axis in germ cell tumors and its targetability using nanobody-drug-conjugates
Being stimulated by the chemokine CXCL12, the CXCR4 / CXCR7 cascade is involved in tumor proliferation, ...
Experimental Hematology & Oncology
comment
0
thumb_up
0
Single VHH-directed BCMA CAR-NK cells for multiple myeloma
Natural killer (NK) cells are promising alternatives for the production of “off-the-shelf” CAR products, posin...
Experimental Hematology & Oncology
comment
0
thumb_up
0
Deciphering tumor-infiltrating dendritic cells in the single-cell era
Dendritic cells (DCs) serve as a pivotal link connecting innate and adaptive immunity by processing tumor-derived antigens...
Experimental Hematology & Oncology
comment
0
thumb_up
0
The current landscape of using direct inhibitors to target KRASG12C-mutated NSCLC
Mutation in KRAS protooncogene represents one of the most common genetic alterations in NSCLC and has posed a great therap...
Experimental Hematology & Oncology
comment
0
thumb_up
0
Downregulation of pro-surfactant protein B contributes to the recurrence of early-stage non-small cell lung cancer by activating PGK1-mediated Akt signaling
Recurrence is one of the main causes of treatment failure in early-stage non-small cell lung cancer (NSCLC). However, ther...
Experimental Hematology & Oncology
comment
0
thumb_up
0
CRISPR/Cas9 system: recent applications in immuno-oncology and cancer immunotherapy
Clustered regulatory interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) is essentially an a...
Experimental Hematology & Oncology
comment
0
thumb_up
0
Chinese expert consensus on Bruton tyrosine kinase inhibitors in the treatment of B-cell malignancies
Targeted therapy with Bruton tyrosine kinase (BTK) inhibitors have revolutionized the treatment of patients with various B...
Experimental Hematology & Oncology
comment
0
thumb_up
0
New insight into circRNAs: characterization, strategies, and biomedical applications
Circular RNAs (circRNAs) are a class of covalently closed, endogenous ncRNAs. Most circRNAs are derived from exonic or int...
Experimental Hematology & Oncology
comment
0
thumb_up
0
Targeting CD22 for B-cell hematologic malignancies
CD19-targeted chimeric receptor antigen (CAR)-T cell therapy has shown remarkable clinical efficacy in the treatment of re...
Experimental Hematology & Oncology
comment
0
thumb_up
0
CRISPR/Cas9-mediated knockout of intracellular molecule SHP-1 enhances tumor-killing ability of CD133-targeted CAR T cells in vitro
CAR T cell therapy has been successfully used in the treatment of hematological malignancies, and the strategy that deleti...
Experimental Hematology & Oncology
comment
0
thumb_up
0
Regulatory T cells contribute to the immunosuppressive phenotype of neutrophils in a mouse model of chronic lymphocytic leukemia
Impaired neutrophil activity is an important issue in chronic lymphocytic leukemia (CLL), as it contributes to a dysfuncti...
Experimental Hematology & Oncology
comment
0
thumb_up
0
Correction to: Bispecific antibodies and dual-targeting CAR-T cells for multiple myeloma: latest updates from the 2023 ASCO annual meeting
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, whi...
Experimental Hematology & Oncology
comment
0
thumb_up
0
Identification of a novel NPM1 mutation in acute myeloid leukemia
Nucleophosmin (NPM1) is a widely expressed nucleocytoplasmic shuttling protein with prominent nucleolar localization. It i...
Experimental Hematology & Oncology
comment
0
thumb_up
0
Targeting and cytotoxicity of chimeric antigen receptor T cells grafted with PD1 extramembrane domain
Immunosuppression induced by programmed cell death protein 1 (PD1) presents a significant constraint on the effectiveness ...
Experimental Hematology & Oncology
comment
0
thumb_up
0
Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target
Immunotherapy has emerged as an effective treatment for various types of cancers. Recent studies have highlighted a signif...
Experimental Hematology & Oncology
comment
0
thumb_up
0
Focal adhesion kinase: from biological functions to therapeutic strategies
Focal adhesion kinase (FAK), a nonreceptor cytoplasmic tyrosine kinase, is a vital participant in primary cellular functio...
Experimental Hematology & Oncology
comment
0
thumb_up
0
The PTX3/TLR4 autocrine loop as a novel therapeutic target in triple negative breast cancer
The pattern recognition receptor long pentraxin-3 (PTX3) plays conflicting roles in cancer by acting as an oncosuppressor ...
Experimental Hematology & Oncology
comment
0
thumb_up
0
A novel CAR-T cell product targeting CD74 is an effective therapeutic approach in preclinical mantle cell lymphoma models
Mantle cell lymphoma (MCL) is a rare B-cell non-Hodgkin lymphoma subtype which remains incurable despite multimodal approa...
Experimental Hematology & Oncology
comment
0
thumb_up
0
Recent advances and future perspectives in the therapeutics of prostate cancer
Prostate cancer (PC) is one of the most common cancers in males and the fifth leading reason of death. Age, ethnicity, fam...
Experimental Hematology & Oncology
comment
0
thumb_up
0
Modelling acquired resistance to DOT1L inhibition exhibits the adaptive potential of KMT2A-rearranged acute lymphoblastic leukemia
In KMT2A-rearranged acute lymphoblastic leukemia (ALL), an aggressive malignancy, oncogenic KMT2A-fusion proteins inapprop...
Experimental Hematology & Oncology
comment
0
thumb_up
0
阅读更多
Modal title
×
Modal title
×
分享
登入
Global News and Health Forum
Join Now!
馬上登入
記住我
忘記密碼?
或者使用
Linkedin